Associations between aberrant splicing and clinical variables or patient survival. (A-C) Scatterplots of aberrant splicing values in AP1G2 (A), DOM3Z (B), and ERCC3 (C) and neutrophil counts (ANC) in patients with MDS. (D) Scatterplot of aberrant splicing values in NICN1 and platelet counts in patients with MDS. (E-H) Kaplan-Meier survival plots for individual isoforms of PTPRC and IFI44L in our MDS cohort (E and G, respectively), and the Cancer Genome Atlas AML cohort (F and H, respectively).